Sarepta Therapeutics (SRPT) Posts Q4 Loss of 77c/Share; Guides

February 27, 2014 7:10 AM

Sarepta Therapeutics (NASDAQ: SRPT) reported Q4 EPS of ($0.77), $0.08 worse than the analyst estimate of ($0.69). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found